BCYC
Price
$11.66
Change
-$0.34 (-2.83%)
Updated
Feb 21 closing price
Capitalization
805.08M
9 days until earnings call
RPTX
Price
$1.29
Change
-$0.03 (-2.27%)
Updated
Feb 21 closing price
Capitalization
54.84M
9 days until earnings call
Ad is loading...

BCYC vs RPTX

Header iconBCYC vs RPTX Comparison
Open Charts BCYC vs RPTXBanner chart's image
Bicycle Therapeutics
Price$11.66
Change-$0.34 (-2.83%)
Volume$488.87K
Capitalization805.08M
Repare Therapeutics
Price$1.29
Change-$0.03 (-2.27%)
Volume$138.49K
Capitalization54.84M
BCYC vs RPTX Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RPTX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and RPTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (BCYC: $11.66 vs. RPTX: $1.29)
Brand notoriety: BCYC and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 141% vs. RPTX: 34%
Market capitalization -- BCYC: $805.08M vs. RPTX: $54.84M
BCYC [@Biotechnology] is valued at $805.08M. RPTX’s [@Biotechnology] market capitalization is $54.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 3 bearish.
  • RPTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than RPTX.

Price Growth

BCYC (@Biotechnology) experienced а -7.09% price change this week, while RPTX (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

BCYC is expected to report earnings on May 01, 2025.

RPTX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($805M) has a higher market cap than RPTX($54.8M). RPTX YTD gains are higher at: -1.527 vs. BCYC (-16.714). RPTX has higher annual earnings (EBITDA): -90.24M vs. BCYC (-160.02M). BCYC has more cash in the bank: 891M vs. RPTX (179M). RPTX has less debt than BCYC: RPTX (2.56M) vs BCYC (11.1M). RPTX has higher revenues than BCYC: RPTX (66.5M) vs BCYC (36.9M).
BCYCRPTXBCYC / RPTX
Capitalization805M54.8M1,469%
EBITDA-160.02M-90.24M177%
Gain YTD-16.714-1.5271,095%
P/E RatioN/AN/A-
Revenue36.9M66.5M55%
Total Cash891M179M498%
Total Debt11.1M2.56M433%
TECHNICAL ANALYSIS
Technical Analysis
BCYCRPTX
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AINIX15.22-0.03
-0.20%
Ariel International Institutional
PIGCX25.89-0.23
-0.88%
Putnam International Equity C
VFSNX225.11-1.99
-0.88%
Vanguard FTSE All-Wld ex-US SmCp Idx Ins
FCGPX19.78-0.20
-1.00%
NYLI PineStone Global Equity Class P
FSCEX14.83-0.39
-2.56%
Fidelity Advisor Small Cap C

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.83%
RPTX - BCYC
48%
Loosely correlated
-2.27%
INO - BCYC
42%
Loosely correlated
+0.90%
XNCR - BCYC
41%
Loosely correlated
-0.32%
RLAY - BCYC
37%
Loosely correlated
-4.16%
FHTX - BCYC
37%
Loosely correlated
-2.79%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-2.27%
INO - RPTX
50%
Loosely correlated
+0.90%
BCYC - RPTX
48%
Loosely correlated
-2.83%
ALNY - RPTX
38%
Loosely correlated
-0.16%
AXON - RPTX
37%
Loosely correlated
-5.28%
GSGTF - RPTX
34%
Loosely correlated
N/A
More